First Edition: Feb. 11, 2022
Today's early morning highlights from the major news organizations.
The independent source for health policy research, polling, and news.
11,881 - 11,900 of 112,425 Results
Today's early morning highlights from the major news organizations.
Opinion writers examine these covid topics.
Editorial writers tackle these public health issues.
Tonga had been almost entirely free of covid, but is now seeing community spread driven by omicron and the complexities of recovery after a volcanic eruption. Meanwhile, in the U.K. — despite relatively high infection rates — most remaining covid restrictions will be dropped.
Each week, KHN compiles a selection of recently released health policy studies and briefs.
Young children are at highest risk from exposure to the toxic chemicals, a George Washington University study says. Separate research links preterm births with fertility treatments, and another study says eating more legumes and less red meat is linked to longer lifespans.
A CDC report says the majority of states with lowest life expectancies were in the South. Mississippi had the lowest of all: 74.4 years. In other news, Georgia advanced a bill banning mailed abortion pills; UCLA settled a physician sexual abuse lawsuit for $243.6 million; and more.
In the light of a controversial Florida bill limiting discussion of LGBTQ+ topics in schools, President Joe Biden addressed the LGBTQ+ community, and particularly children who may be affected, to stress his support for them. Transgender rights issues are reported by other news outlets.
Senate Finance Committee chair Ron Wyden says he endorses Robert Califf to lead the Food and Drug Administration. His endorsement is the latest in a line of Senate Democrats who say their concerns about his nomination have been allayed. A full Senate vote has not yet been scheduled.
Keytruda, a.k.a. pembolizumab, is the subject of a Press Association report that highlights how effective it is against certain aggressive breast cancers if given with chemotherapy. Everly Health, Roche in South Africa, an expensive cystic fibrosis drug and more are also in the news.
President Joe Biden will address the high cost of prescription drugs during an event Thursday, an issue on which there is some bipartisan support and could help the White House make some progress on its stalled domestic agenda.
The CDC is reportedly poised to quickly roll out 10 million doses. The FDA has yet to authorize the lower-dose, 3-microgram Pfizer/BioNTech shot for children ages 6 months to 4.
One researcher is reported as saying the results of a new study were "stunning" in terms of the increased risk of heart illnesses a year after even a mild covid infection. Different research finds a prior infection is less protective against catching omicron than other variants.
President Joe Biden's requirement that all federal employees get vaccinated against covid remains on hold after the 5th US Circuit Court of Appeals voted 2-1 not to lift a lower court's ruling. The case is likely heading to the Supreme Court.
CDC Director Dr. Rochelle Walensky stressed that it is too soon for all Americans to take off their masks in indoor public places. But Politico reports that CDC staff are considering whether the agency should use case rates as a metric or whether it should use hospitalization data.
Some states, like New York, will still require masks in schools. Others, like Massachusetts and Rhode Island, will make them optional for students. Some parents and doctors say it's too risky, too soon.
Today's early morning highlights from the major news organizations.
Editorial writers delve into these public health issues.
Read about the biggest pharmaceutical developments and pricing stories from the past week in KHN's Prescription Drug Watch roundup.
Read recent commentaries about drug-cost issues.
© 2026 KFF